|
Dr. Mello Known as a technological innovator in the field of molecular genetics, Craig C. Mello, Ph.D., together with Andrew Fire, Ph.D., was awarded the Nobel Prize in medicine for discovery of the use of double-stranded RNA for gene silencing, a technology that has come to be known as RNA interference (RNAi). Dr. Mello is the Blais University Chair and Distinguished Professor of Molecular Medicine and a Howard Hughes Medical Institute Investigator at the University of Massachusetts Medical School, in Worcester, Massachusetts. In this capacity, Dr. Mello studies both the biochemical pathway responsible for RNAi and the regulation of gene expression; he has numerous publications credits including 16 in the prestigious journals Science, Nature, Cell, and the Proceedings of the National Academy of Sciences. Prior to joining the University of Massachusetts Medical School, Dr. Mello was a post-doctoral fellow in the lab of Dr. Jim Priess at the Fred Hutchinson Cancer Research Center in Seattle. Dr. Mello received a Ph.D. from Harvard University and a Sc.B. from Brown University. He also conducted graduate studies in the laboratory of David Hirsh, Ph.D., at the University of Colorado. In 2003, Dr. Mello shared the Wiley Foundation Prize and the prestigious National Academy of Sciences Award in Molecular Biology with Dr. Fire for their work on RNAi. | 